Application 078339
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 200MG BASE/VIAL | No | No |
| 002 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-0185 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0185 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0185 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0185 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0186 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0186 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0186 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |
| 0409-0186 | Gemcitabine | GEMCITABINE | Hospira, Inc. | ANDA | Current |